Drugs / RG-7600
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01469793 | Nov 2011 → Dec 2015 | ovarian cancer | Genentech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG-7600 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2109281 ↗ |
| Known as | DMOT4039A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01469793 ↗ |
| Target | MSLN | “Mesothelin binding agent” CHEMBL2109281 ↗ |